Chengda Pharmaceuticals Co.,Ltd.’s Net Profit Rose 30.7% in First Three Quarters of 2022

Chengda Pharmaceuticals Co.,Ltd. (诚达药业股份有限公司) (301201.SZ) reported a net profit of 92 million yuan in the first three quarters of 2022, up 30.7% year-on-year.

Meanwhile, the company posted 305.6 million yuan in revenue, up 5.4% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 88.9 million yuan in total liabilities, with a liability-to-asset ratio of 3.9%.